Eli Lilly has announced it is lowering the price of insulin by 70%, capping its out-of-pocket cost at $35, and offering its generic insulin at $25. The move follows years of organizing and pressure from activists, lawmakers, and people with diabetes. In response, Senator Bernie Sanders wrote to the drug companies Sanofi and Novo Nordisk demanding they follow suit. Sanders wrote, “Insulin is not a new drug. It was discovered 100 years ago by Canadian scientists who sold the patent rights of insulin for just $1 because they wanted to save lives, not make pharmaceutical executives extremely wealthy. And yet, as a result of unacceptable corporate greed, the price of insulin has gone up by over 1,000 percent since 1996 causing 1.3 million people with diabetes to ration insulin last year while your companies made billions of dollars in profits.”